Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Marketed pharmaceutical medicines constantly evolve throughout their lifecycles – new indications, improved formulations or packaging, updated manufacturing methods, validity period extensions, labeling updates and more.
With increasing global regulatory requirements, maintaining compliance of the products in your portfolio is essential to your right-to-operate.
Detailed planning and proper tracking of lifecycle management (LCM) across all relevant geographies are key to ensuring the full value of your products, helping you to avoid duplicative activities, reduce non-compliance risks and efficiently manage your regulatory expertise.
In this webinar, participants will build a better understanding of:
Vice President, Global Regulatory Affairs
IQVIA
Dr. Christina (Chris) Bodurow received her Bachelors in Science from Kalamazoo College, and her Ph.D. in Organic Chemistry from Princeton University. Chris is currently Vice-President, Global Regulatory Affairs, in the Data Sciences, Safety and Regulatory Division at IQVIA. Chris’ prior experience includes 33 years at Eli Lilly and Company. She held responsibilities including Senior Director of External Sourcing in the Medicines Development Unit (MDU), Chief Operating Officer (COO), Product Research & Development (CMC component of LRL), as well as global R&D Operations Leader for the Prozac and Xigris Product Teams. Chris Bodurow has served in a number of professional and community volunteer roles, including on the Board of Directors of the American Chemical Society, the Chemistry Advisory Board for Princeton Chemistry, the Board of Directors of the Indianapolis Symphony Orchestra and the Kalamazoo College Board of Trustees.
Custom Content Writer
Informa Pharma Intelligence